Tagaloguin, Glecel C.

HRN: 15-48-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
CEFUROXIME 1.5GM (VIAL)
04/23/2022
04/23/2022
IVT
1.5g
On Call To OR
Incomplete Abortion
Waiting Final Action 
04/23/2022
CEFUROXIME 500MG (TAB)
04/23/2022
04/29/2022
ORAL
500mg
BID
Incomplete Abortion
Waiting Final Action 
12/21/2023
CEFUROXIME 500MG (TAB)
12/21/2023
12/28/2023
PO
1 Tab
BID
Incomplete Abortion
Waiting Final Action 
12/22/2023
METRONIDAZOLE 500MG (TAB)
12/22/2023
12/29/2023
PO
500mg
BID X 7 Days
S/P Completion Curettage
Waiting Final Action 
12/22/2023
METRONIDAZOLE 500MG (TAB)
12/22/2023
12/29/2023
PO
500mg
BID X 7 Days
S/P Completion Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: